Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
4.710
-0.030 (-0.63%)
Jul 30, 2026, 11:54 AM EDT - Market open

Foghorn Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
277306262273267945
Market Cap Growth
-23.67%16.59%-3.78%2.25%-71.76%26.65%
Enterprise Value
136.67188.3355.7983.74-27.59848.57
Last Close Price
4.715.404.726.456.3822.87

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
9.869.9011.617.9813.87716.09
PB Ratio
--2.82-5.76-3.532381.309.75
P/TBV Ratio
----2369.238.78
P/FCF Ratio
----1.39-
P/OCF Ratio
----1.38-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
4.846.092.472.45-1.43643.34
EV/EBITDA Ratio
----0.24-
EV/EBIT Ratio
----0.24-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.53-0.37-0.62-0.47406.580.53
Debt / FCF Ratio
----0.27-
Net Debt / Equity Ratio
1.851.084.542.45-2627.60-0.99
Net Debt / EBITDA Ratio
1.721.422.081.812.590.98
Net Debt / FCF Ratio
1.621.372.041.58-1.531.79
Asset Turnover
0.130.130.080.100.040.00
Quick Ratio
2.852.663.644.016.263.17
Current Ratio
2.922.733.734.116.379.44
Return on Equity (ROE)
81.47%96.45%141.17%233.46%-224.54%-81.34%
Return on Assets (ROA)
-40.47%-35.84%-36.04%-29.84%-25.34%-25.98%
Return on Invested Capital (ROIC)
-57.44%-48.62%-46.20%---464.99%
Return on Capital Employed (ROCE)
-57.44%-48.62%-46.20%-37.39%-28.54%-28.46%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
FCF Yield
----72.14%-
Buyback Yield / Dilution
-7.75%-14.72%-30.79%-0.92%-11.89%0.00%
Total Shareholder Return
-7.75%-14.72%-30.79%-0.92%-11.89%0.00%
SEC Filings: 10-K · 10-Q